(Q44658965)

5 December 2017

title

Anatomical and functional cerebral variables associated with basal symptoms but not risperidone response in minimally treated schizophrenia (English)

1 reference

5 December 2017

0 references

1 reference

6

1 reference

5 December 2017

10

1 reference

5 December 2017

Javier Pascau

3

0 references

Vicente Molina

object named as

Vicente Molina

1

0 references

author name string

Santiago Reig

2

1 reference

5 December 2017

Javier Sanz

4

1 reference

5 December 2017

Fernando Sarramea

5

1 reference

5 December 2017

Rogelio Luque

7

1 reference

5 December 2017

Carlos Benito

8

1 reference

5 December 2017

Tomás Palomo

9

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

5 December 2017

1 reference

5 December 2017

volume

124

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

163-175

1 reference

Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Automatic atlas-based volume estimation of human brain regions from MR images

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Multimodal image coregistration and partitioning--a unified framework.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Voxel-based morphometry–the methods

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Striatal metabolic rate and clinical response to neuroleptics in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings, and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Sex differences in neuroanatomical and clinical correlations in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Cerebral metabolic patterns in chronic and recent-onset schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Multimodality image quantification using the Talairach grid

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Symptom dimensions and brain morphology in schizophrenia and related psychotic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

The left medial temporal region and schizophrenia. A PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Functional and anatomical aspects of prefrontal pathology in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Neuroimaging in schizophrenia research

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Impaired recruitment of the hippocampus during conscious recollection in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Neuronal death enhanced by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Three clinical syndromes of schizophrenia in untreated subjects: relation to brain glucose activity measured by positron emission tomography (PET)

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Automated Talairach atlas-based parcellation and measurement of cerebral lobes in children

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Association between regional brain volumes and clozapine response in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Patterns of cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Immediate effects of risperidone on cortico-striato-thalamic loops and the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Executive-frontal lobe cognitive dysfunction in schizophrenia: a symptom subtype analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

P300 amplitude as a possible correlate of frontal degeneration in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Association between relative temporal and prefrontal sulcal cerebrospinal fluid and illness duration in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Cerebral metabolism and risperidone treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Anatomical and functional brain variables associated with clozapine response in treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Fronto-striato-thalamic perfusion and clozapine response in treatment-refractory schizophrenic patients. A 99mTc-HMPAO study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Cerebral metabolic activity correlates of subsyndromes in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Structural and functional correlates of subsyndromes in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

A review of MRI findings in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

A functional neuroanatomy of hallucinations in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Reduced GABA uptake sites in the temporal lobe in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Patterns of regional cortical dysmorphology distinguishing schizophrenia and chronic alcoholism.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Depression of thalamic metabolism by lorazepam is associated with sleepiness.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

Negative symptoms and hypofrontality in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

MRI-PET registration with automated algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

MRI correlates of treatment response in first episode psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4927%2803%2900107-0

7 January 2021

10.1016/S0925-4927(03)00107-0

Identifiers

DOI

1 reference

5 December 2017

1 reference